antibiotics and glp 1 TrimRX Antibiotics & Semaglutide: Safety, Drug

Spencer JP, Thomas S, Trondsen Pawlowski RH

4.6(115) Limited time WeightCare Recharge Your Body: 10 B12 BioBoost Shots + Telemedicine Consultation

Amgen announced positive results from a Phase II clinical trial evaluating its investigational obesity drug MariTide (maridebart cafraglutide, formerly AMG 133) for the treatment of obesity and overweight in both diabetic and non-diabetic patients

The analysis reviewed outcomes from more than 430,000 patients and reinforces the growing evidence that metabolic surgery remains one of the most effective and durable treatments for severe obesity

Gut microbiome modulation Emerging evidence suggests berberine may alter intestinal bacterial composition, which could indirectly influence metabolic parameters